In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QSI Pharma AS

Executive Summary

QSI Pharma, a Danish start up formed by the Technical University of Denmark and the biotech incubator of Leo Pharma AS, aims to inhibit the formation of deadly biofilms, highly structured and virulent communities of surface colonizing bacteria. QSI aims to discover molecules that interfere with bacterial quorum sensing, a cell-cell signaling process by which bacteria form biofilms when sufficient bacteria have amassed. The company's first target is Pseudomonas aeruginosa, which is responsible for a significant percentage of deaths from many hospital-acquired infections.

Related Content


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts